Clinical Trial: A Study of LY3549492 in Healthy Weight Adult Participants

U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07085468) titled 'A Study of LY3549492 in Healthy Weight Adult Participants' on July 18.

Brief Summary: The main purpose of this study is to evaluate the safety and tolerability of LY3549492 in adult participants with a healthy body max index (BMI) of 22 to 25 kilograms per square meter (kg/m2).

Participation in the study will last about 13 months.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: LY3549492

Administered orally

DRUG: Placebo

Administered orally

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eli Lilly and Company

Published by HT Digital Content Services with permission from Hea...